Evaluation of the pharmaceuticals industry investment program
Submissions
* Submissions marked with an asterisk have omitted 'In confidence' content - part or all of the submission is not online.
# Hash denotes some attachments are not available online. Contact the project team for access if necessary.
% Percent symbol denotes scanned image PDFs which are not readable by some screen readers. For help read our accessibility statement.
Copyright in submissions resides with the author(s), not with the Productivity Commission.
All submissions will remain on the Commission's website indefinitely.
| No. | Individual / Organisation | Date | Pages | File/s | |
|---|---|---|---|---|---|
| 1 |
Association of Australian Medical Research Institutes
|
16/09/2002 | 2 | ||
| 2 |
Merck Sharp & Dohme (Australia) Pty Limited
|
14/10/2002 | 9 | ||
| 3 |
Department of Innovation, Industry and Regional Development
|
04/11/2002 | 25 | ||
| 4 |
Mayne Pharma *
|
06/11/2002 | 23 | ||
| 8 |
Industry Tourism Resources
|
15/01/2003 | 9 | ||
| 9 |
Eli Lilly Australia Pty Limited
|
15/01/2003 | 20 | ||
| 10 |
Medicines Australia
|
15/01/2003 | 49 | ||
| 11 |
Merck Sharp & Dohme
|
16/01/2003 | 37 | ||
| 12 |
Pfizer
|
30/01/2003 | 37 | ||
| 13 |
CSL limited
|
16/01/2003 | 2 | ||
| 14 |
Ausbiotech
|
16/01/2003 | 8 | ||
| 15 |
Victoria University
|
17/01/2003 | 15 | ||
| 16 |
Department of State and Regional Development
|
17/01/2003 | 5 | ||
| 17 |
Bristol-Myers Squibb Australia Pty Ltd *
|
20/01/2003 | 22 | ||
| 18 |
ARI (ANSTO)
|
30/01/2003 | 3 |